Literature DB >> 2365769

Analysis of blood and urine samples from Macaca mulata for pyronaridine by high-performance liquid chromatography with electrochemical detection.

S A Wages1, L C Patchen, F C Churchill.   

Abstract

We describe a high-performance liquid chromatographic method with electrochemical detection for quantifying pyronaridine in rhesus monkey (Macaca mulata) blood and urine samples. The detection limit is 20 ng/ml at a signal-to-noise ratio of 4 in 0.5-ml samples of blood or urine. Blood analysis includes a liquid-liquid extraction and a subsequent solid-phase extraction that removes an interferent present in blood. For urine, a back-extraction is substituted for the solid-phase extraction step. The method uses an analogue of amodiaquine as internal standard, a 10-microns rigid macroporous styrene-divinylbenzene copolymer column and a mobile phase of 1% (v/v) triethylamine in methanol-water (34:66, v/v). The method was applied to samples of blood and urine from a monkey after a single intramuscular dose of pyronaridine tetraphosphate (160 mg as base).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365769     DOI: 10.1016/s0378-4347(00)82088-5

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley rats.

Authors:  Sang Hyun Park; Kannampalli Pradeep
Journal:  J Biomed Biotechnol       Date:  2010-03-31

2.  Review of pyronaridine anti-malarial properties and product characteristics.

Authors:  Simon L Croft; Stephan Duparc; Sarah J Arbe-Barnes; J Carl Craft; Chang-Sik Shin; Lawrence Fleckenstein; Isabelle Borghini-Fuhrer; Han-Jong Rim
Journal:  Malar J       Date:  2012-08-09       Impact factor: 2.979

3.  Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - Increased sensitivity resulting from reduced non-specific binding.

Authors:  Daniel Blessborn; Karnrawee Kaewkhao; Lijiang Song; Nicholas J White; Nicholas P J Day; Joel Tarning
Journal:  J Pharm Biomed Anal       Date:  2017-08-26       Impact factor: 3.935

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.